DK172221B1 - Anvendelse af ACE-inhibitorer eller deres fysiologisk acceptable salte til fremstilling af lægemidler med nootrop virkning - Google Patents
Anvendelse af ACE-inhibitorer eller deres fysiologisk acceptable salte til fremstilling af lægemidler med nootrop virkning Download PDFInfo
- Publication number
- DK172221B1 DK172221B1 DK153587A DK153587A DK172221B1 DK 172221 B1 DK172221 B1 DK 172221B1 DK 153587 A DK153587 A DK 153587A DK 153587 A DK153587 A DK 153587A DK 172221 B1 DK172221 B1 DK 172221B1
- Authority
- DK
- Denmark
- Prior art keywords
- carboxylic acid
- alanyl
- carbethoxy
- pyrrolidine
- octane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Enzymes And Modification Thereof (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863610391 DE3610391A1 (de) | 1986-03-27 | 1986-03-27 | Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen |
DE3610391 | 1986-03-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK153587D0 DK153587D0 (da) | 1987-03-26 |
DK153587A DK153587A (da) | 1987-09-28 |
DK172221B1 true DK172221B1 (da) | 1998-01-12 |
Family
ID=6297417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK153587A DK172221B1 (da) | 1986-03-27 | 1987-03-26 | Anvendelse af ACE-inhibitorer eller deres fysiologisk acceptable salte til fremstilling af lægemidler med nootrop virkning |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0243645B1 (cs) |
JP (1) | JPS62240698A (cs) |
KR (1) | KR870008841A (cs) |
CN (1) | CN1031267C (cs) |
AT (1) | ATE102954T1 (cs) |
AU (1) | AU621278B2 (cs) |
CA (1) | CA1341064C (cs) |
CS (2) | CS651989A3 (cs) |
DD (1) | DD280765A5 (cs) |
DE (2) | DE3610391A1 (cs) |
DK (1) | DK172221B1 (cs) |
EG (1) | EG18175A (cs) |
ES (1) | ES2061447T3 (cs) |
FI (1) | FI91876C (cs) |
HU (2) | HU203117B (cs) |
IE (1) | IE62456B1 (cs) |
MA (1) | MA20919A1 (cs) |
NO (1) | NO178546C (cs) |
NZ (1) | NZ219764A (cs) |
OA (1) | OA08506A (cs) |
PH (1) | PH27210A (cs) |
PT (1) | PT84564B (cs) |
RU (1) | RU1836335C (cs) |
TN (1) | TNSN87045A1 (cs) |
ZA (1) | ZA872230B (cs) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
AU612137B2 (en) * | 1987-04-27 | 1991-07-04 | E.R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing an ace inhibitor |
DE3731085A1 (de) * | 1987-09-16 | 1989-04-06 | Hoechst Ag | Neue aminosaeureester, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
DE3801587A1 (de) * | 1988-01-21 | 1989-08-03 | Hoechst Ag | Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
EP0331609A3 (de) * | 1988-01-27 | 1992-07-01 | Hoechst Aktiengesellschaft | Angiotensin-Converting-Enzym-Hemmstoffe mit psychotroper Wirkung |
DE3803225A1 (de) * | 1988-02-04 | 1989-08-17 | Hoechst Ag | Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung |
JPH01275529A (ja) * | 1988-03-21 | 1989-11-06 | E R Squibb & Sons Inc | 晩発性運動障害の抑制治療剤 |
US5037821A (en) * | 1988-06-01 | 1991-08-06 | E. R. Squibb & Sons, Inc. | Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor |
US5093129A (en) * | 1989-01-30 | 1992-03-03 | E. R. Squibb & Sons, Inc. | Method for treating addiction to a drug of abuse employing an ace inhibitor |
US5032578A (en) * | 1990-09-17 | 1991-07-16 | E. R. Squibb & Sons, Inc. | Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
JP2004532200A (ja) * | 2001-03-15 | 2004-10-21 | サエジス ファーマシューティカルズ, インコーポレイテッド | 全身性ストレスの後に認識機能を回復するための方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU88621I2 (fr) * | 1980-10-23 | 1995-09-01 | Schering Corp | Sandopril |
DE3300774A1 (de) * | 1983-01-12 | 1984-07-12 | Hoechst Ag, 6230 Frankfurt | Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung |
-
1986
- 1986-03-27 DE DE19863610391 patent/DE3610391A1/de not_active Withdrawn
-
1987
- 1987-03-18 AT AT87103938T patent/ATE102954T1/de not_active IP Right Cessation
- 1987-03-18 EP EP87103938A patent/EP0243645B1/de not_active Expired - Lifetime
- 1987-03-18 DE DE87103938T patent/DE3789330D1/de not_active Expired - Lifetime
- 1987-03-18 ES ES87103938T patent/ES2061447T3/es not_active Expired - Lifetime
- 1987-03-25 DD DD87301118A patent/DD280765A5/de not_active IP Right Cessation
- 1987-03-25 EG EG18087A patent/EG18175A/xx active
- 1987-03-25 HU HU871308A patent/HU203117B/hu unknown
- 1987-03-25 PH PH35073A patent/PH27210A/en unknown
- 1987-03-25 FI FI871304A patent/FI91876C/fi not_active IP Right Cessation
- 1987-03-25 HU HU896609A patent/HU202118B/hu unknown
- 1987-03-25 MA MA21159A patent/MA20919A1/fr unknown
- 1987-03-25 NZ NZ219764A patent/NZ219764A/en unknown
- 1987-03-26 NO NO871282A patent/NO178546C/no unknown
- 1987-03-26 IE IE78487A patent/IE62456B1/en not_active IP Right Cessation
- 1987-03-26 ZA ZA872230A patent/ZA872230B/xx unknown
- 1987-03-26 KR KR870002775A patent/KR870008841A/ko not_active Ceased
- 1987-03-26 PT PT84564A patent/PT84564B/pt unknown
- 1987-03-26 JP JP62070541A patent/JPS62240698A/ja active Pending
- 1987-03-26 RU SU874202302A patent/RU1836335C/ru active
- 1987-03-26 DK DK153587A patent/DK172221B1/da not_active IP Right Cessation
- 1987-03-26 AU AU70649/87A patent/AU621278B2/en not_active Expired
- 1987-03-26 CA CA000533092A patent/CA1341064C/en not_active Expired - Lifetime
- 1987-03-27 TN TNTNSN87045A patent/TNSN87045A1/fr unknown
- 1987-03-27 CN CN87102304A patent/CN1031267C/zh not_active Expired - Lifetime
- 1987-03-27 CS CS896519A patent/CS651989A3/cs not_active IP Right Cessation
- 1987-03-27 OA OA59095A patent/OA08506A/xx unknown
- 1987-03-27 CS CS872126A patent/CS212687A3/cs unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK172221B1 (da) | Anvendelse af ACE-inhibitorer eller deres fysiologisk acceptable salte til fremstilling af lægemidler med nootrop virkning | |
DK161523B (da) | Analogifremgangsmaade til fremstilling af optisk aktive eller racemiske dipeptidderivater eller farmaceutisk acceptable salte heraf | |
US5256687A (en) | Pharmaceutical composition for the treatment of high blood pressure | |
DK159419B (da) | Analogifremgangsmaade til fremstilling af substituerede acylderivater af octahydro-1h-indol-2-carboxylsyrer | |
JPH02104526A (ja) | 高血圧症治療用組成物 | |
IE59975B1 (en) | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs | |
AU594711B2 (en) | A method for the treatment of atherosclerosis, thrombosis and peripheral vesseldisease | |
JPS59134765A (ja) | 新規なスピロ環式アミノ酸誘導体およびそれらの製造法 | |
US5231084A (en) | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons | |
US5231080A (en) | Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease | |
US5091427A (en) | Piperazinediones having a psychotropic action | |
AU594969B2 (en) | Amino acid derivatives | |
NO306979B1 (no) | Fremgangsmåte for fremstilling av et farmasoeytisk preparat for behandling av kardial så vel som vaskulaer hypertrofi og hyperplasi | |
JPH0531544B2 (cs) | ||
JPH029896A (ja) | 新規アミノ酸グリセリドおよびその製法 | |
AU615252B2 (en) | Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system | |
US5114962A (en) | New amino acid esters, a process for their preparation, medicaments containing them, and the use thereof | |
JPH02200668A (ja) | 向精神作用を有するピロリドン‐2‐カルボン酸誘導体 | |
EP0326974A1 (de) | Aminosäureamide mit psychotroper Wirkung, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und deren Verwendung | |
AU597270B2 (en) | A pharmaceutical composition for the treatment of high blood pressure | |
KR900003321B1 (ko) | 인식보조작용이 있는 화합물, 이를 함유하는 제제 및 인식 기능 장애를 치료하고 예방하는데 있어서 이의 용도 | |
DE3901291A1 (de) | Verbindungen mit psychotroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe von stoerungen des zentralen nervensystems | |
JPH0416479B2 (cs) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PUP | Patent expired |